Therapixel receives FDA 510(k) clearance for MammoScreen™

AI-powered reading aid for screening mammography improves Radiologists’ performance in cancer detection


0 Comments4 Minutes

Therapixel presents the results of its Reader study at the Virtual ECR 2020

Do not miss our research presentation (RPS 702-7) at the "Artificial intelligence, radiomics and more" session


0 Comments1 Minutes

Therapixel to showcase its advanced AI for breast cancer screening at the Digital edition of ECR 2020

Visit our online booth to experience MammoScreen (Expo Hall X1, The Artificial Intelligence Exhibition)


0 Comments4 Minutes

Therapixel: DREAM Digital Mammography Challenge winner

Therapixel came in first place in the breast cancer screening AI competition having developed an algorithm that improved false-positive rate by 5%*


0 Comments11 Minutes

Therapixel Founder & CSO will speak at RSNA Annual Meeting

Discover our award-winning AI-based algorithm at RSNA on December 4th at 10:30 am, AI Showcase.


0 Comments3 Minutes

Therapixel exhibits at RSNA Annual Meeting 2019

Don’t miss us at RSNA! Come by our booth #10132 to discover MammoScreen™.


0 Comments3 Minutes

Meet us at the Journées de la SFSPM

Find us on booth #2 in Palais du Pharo, Marseille to learn more about our AI-based solution for breast cancer detection.


0 Comments1 Minutes

Our brand-new website

We have launched our new website and we are happy to introduce you to its new look


0 Comments2 Minutes

Breast cancer awareness month

Pink October is Breast Cancer Awareness Month. In honor of Pink October, we highlighted some key facts about breast cancer in the world.


0 Comments6 Minutes

Therapixel secures a €5 million Series A financing and strengthens its governance

Financing enables next phase of deployment of company’s award-winning AI-powered solution for breast cancer screening


0 Comments12 Minutes